Castle biosciences inc.
Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.NEW YORK, Aug. 2, 2013 /PRNewswire/ -- Castle Biosciences Inc. announced that data from studies of its DecisionDx-Melanoma test are being presented today at the Summer Academy Meeting of the ...For more information on DiffDx-Melanoma. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Castle Biosciences, Inc. is heading to Philadelphia for the upcoming IMPSG Symposium on November 9 from 1-7 PM. Join us for a presentation by Matt… Liked by Alyssa Benavidez
An experienced team with deep expertise in discovering, developing, and commercializing diagnostic and prognostic tests. Castle Biosciences offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
At Castle Biosciences, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Castle Biosciences, Inc. 505 South Friendswood Drive Suite 401 Friendswood, TX 77546 United States 866 788 9007 https://castlebiosciences.com. Sector(s): ...
Castle Biosciences Inc’s trailing 12-month revenue is $192.0 million with a -39.3% profit margin. Year-over-year quarterly sales growth most recently was 66.2%. Analysts expect adjusted earnings to reach $-2.723 per share for the current fiscal year. Castle Biosciences Inc does not currently pay a dividend.DecisionDx - Melanoma - Castle Test Info. PHYSICIAN LOGIN | RESEARCHER LOGIN. CONTACT A. REPRESENTATIVE. ORDER A. TEST. TissueCypher®. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Howl’s Moving Castle is a beloved Japanese animated film that has captured the hearts of audiences worldwide since its release in 2004. Based on the novel by Diana Wynne Jones, the film tells the story of a young woman named Sophie who is c...3 Castle Biosciences, Inc, Friendswood, Texas. 4 University of Rochester, Rochester, New York. 5 Icahn School of Medicine at Mount Sinai, New York, New York; Arkansas Dermatology Skin Cancer Center, Little Rock, Arkansas. 6 Oregon Health & Science University, Portland, Oregon.
Nov 2, 2023 · Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe the traditional approach to developing a treatment plan for cancers and other diseases using clinical and pathology factors alone is inadequate and can be improved by incorporating the personalized information our tests provide.
John C. Cheneval is Executive Director-Business Development at Castle Biosciences, Inc. In his past career he was Vice President-Pharma Partnerships at HTG Molecular Diagnostics, Inc. and Executive...
Castle Biosciences, Inc. is a commercial-stage diagnostics company. The Company is focused on providing physicians and their patients with personalized, clinically actionable information to ...Apr 26, 2022 · FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has completed its ... Revenue growth over the past 12 months for CASTLE BIOSCIENCES INC comes in at 55.17%, a number that bests 91.18% of the US stocks we're tracking. Stocks with similar financial metrics, market capitalization, and price volatility to CASTLE BIOSCIENCES INC are SILK, ONTF, IGC, FLGT, and BMRA. Visit CSTL's SEC page to see the company's …Castle Biosciences is a high growth, commercial stage molecular diagnostics company dedicated to helping patients and their physicians make the best possible decisions about their treatment and ...Who can I contact if I have a question? Please call our customer service staff at 866-788-9007 or email [email protected]. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes.Castle Biosciences, Inc. 19.85. +0.47. +2.43%. Castle Biosciences, Inc. (NASDAQ:CSTL) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good afternoon and welcome to Castle Biosciences ...Problem Resolution Specialist at Castle Biosciences, Inc. 1y Report this post I love working at Castle!! Castle Biosciences, Inc. 10,111 followers 1y ...
Cutaneous Squamous Cell Carcinoma. Cutaneous squamous cell carcinoma (SCC), non-melanoma skin cancer, is one of the most common cancers with an estimated incidence of more than 1,000,000 cases in the U.S. each year. Approximately 20% of patients have high-risk factors based on tumor depth, histology, anatomic location, and/or immunosuppression.Apr 4, 2022 · Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that ... Aug 15, 2021 · Castle Biosciences, Inc., 866-788-9007, www.castlebiosciences.com Contractor: Castle Biosciences, Inc. Contract Number: 36F79721D0222 Contract Period: August 15, 2021 to August 14, 2026 Prices Effective: 10/1/2022 FSS Price List SIN# TEST ORDER CODE TEST NAME AND DESCRIPTION CPT CODE UOI FSS PRICE w/IFF ($) 621-200 81529 1. 2,091.70 +34.50(+1.68%) Castle Biosciences, Inc. (CSTL) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 19.97 -0.02 (-0.10%) At close: 04:00PM EST 20.35 +0.38 (+1.90%) After... The primary residents of European castles during the Middle Ages were the lord and lady of the realm. These might be royalty or simply the liege lords of the district where the castle was built.HAYATI Journal of Biosciences (p-ISSN: 1978-3019; e-ISSN: 2086-4094) Department of Biology, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, …Castle Biosciences, Inc is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Castle Biosciences Customer Service Email: [email protected] Call: (412) 820-3050 Billing and Insurance Questions Email: [email protected] Call: 866-788-9007, option #3 For additional information about Castle Biosciences or TissueCypher testing, please go to: …Nov 2, 2023 · Castle Biosciences Reports Third Quarter 2023 Results. Published: Nov 02, 2023. Q3 2023 revenue increased 66% over Q3 2022 to $61 million. Q3 2023 total test reports increased 52% over Q3 2022. Raising full year 2023 revenue guidance to at least $200 million from at least $180 million. Conference call and webcast today at 4:30 p.m. ET.
Alice Izzo has served as our Senior Vice President, Marketing, since April 2022. Ms. Izzo joined Castle in September 2013 as our Executive Director, Marketing, and was promoted to Vice President, Marketing, in March 2018. Prior to joining Castle, Ms. Izzo held various leadership positions at Amylin Pharmaceuticals, including Vice President of ...Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced upcoming presentations on two of its skin cancer gene expression profile (GEP) tests at the 2022 American Academy of Dermatology (AAD) Annual Meeting, being held in Boston, March 25-29, 2022. ...2 Nov 2023 ... FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide ...Complete Castle Biosciences Inc. stock information by Barron's. View real-time CSTL stock price and news, along with industry-best analysis.Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced it has signed a definitive agreement to acquire AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the field of pharmacogenomics (PGx) testing services that ...She is also on the board of Castle Biosciences, Inc. She received a graduate degree and an MBA from Stanford University and an undergraduate degree from Yale University. Current positions of Ellen Goldberg : Name: Title: Since: Castle Biosciences, Inc. (Medical Equipment, Supplies & Distribution)
Jul 10, 2023 · Castle Biosciences, Inc is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Castle Biosciences, Inc. 2022 Inducement Plan (Full title of the plan) Derek J. Maetzold . President and Chief Executive Officer . Castle Biosciences, Inc. 505 S. Friendswood Drive, Suite 401 . Friendswood, Texas 77546 (866) 788-9907
FRIENDSWOOD, Texas, June 03, 2023--Castle will share new data on DecisionDx®-Melanoma and DecisionDx®-UM during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.This Agreement and Plan of Merger (this “ Agreement”) is made and entered into as of October 18, 2021 (the “ Agreement Date”), by and among Castle Biosciences, Inc., a Delaware corporation (“ Acquirer”), Space Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Acquirer (“ Merger Sub”), Cernostics, Inc., a Delaware …Hayward Pool Products Inc. is a leading manufacturer and distributor of swimming pool equipment and supplies. With over 80 years of experience, the company has been at the forefront of innovation in the swimming pool industry.Biosaintifika was established in 2009. Title with the title Biosaintifika Berkala Ilmiah Biologi. Starting from Volume 5 Number 2 September 2013, this journal is only published three …Castle Creek is a portfolio company of Paragon Biosciences, which founded Castle Creek with the vision to deliver transformative therapies to patients with rare genetic dermatologic diseases ...Now $19 (Was $̶3̶8̶) on Tripadvisor: Rooms Inc Hotel, Semarang. See 316 traveler reviews, 561 candid photos, and great deals for Rooms Inc Hotel, ranked #16 of 300 hotels in …April 04, 2022 04:05 PM Eastern Daylight Time. FRIENDSWOOD, Texas-- ( BUSINESS WIRE )--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide ...Apr 5, 2022 · Castle Biosciences to acquire mental health testing co. AltheaDX in deal worth up to $140M. Friendswood-based diagnostics company Castle Biosciences Inc. (Nasdaq: CSTL) will acquire San Diego ... Castle Biosciences, Inc. (CSTL) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. 2W 10W 9M. 19.88 +0.03 (+0.15%) At close: 01:00PM EST. 19.88 0.00 …
“Castle delivered a strong start to the year,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “Building on our strength and momentum from 2022, we delivered significant test report volume and revenue growth in the first quarter, which was driven by continued execution on our short- and long-term strategies.Castle Biosciences has not completed the preparation of its financial statements for the fourth quarter or full-year-ended Dec. 31, 2022.The preliminary, unaudited information presented in this press release for the quarter and year-ended Dec. 31, 2022, is based on management’s initial review of the information presented and its current expectations, …Vice President, Investor Relations & Corporate Affairs. See full bio. Castle Biosciences is a molecular diagnostics company that provides tumor-specific information for improved treatment decisions and patient outcomes. Nov 17, 2023 · Castle Biosciences, Inc. (NASDAQ:CSTL) announced its quarterly earnings results on Sunday, November, 7th. The company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.34) by $0.13. The firm earned $23.48 million during the quarter, compared to the consensus estimate of $23.66 million. Instagram:https://instagram. prime stocksportfolio gradercompare forex brokerselnsf FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced data from a study showing ... austin hankwitzpioneer natural resources company stock FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced upcoming presentations on ... should i sell plug power today Overview. Castle Biosciences is improving health through our innovative tests that guide patient care. For the diseases that our portfolio of tests cover, we believe the traditional approach to developing a treatment plan for cancers and other diseases using clinical and pathology factors alone is inadequate and can be improved by incorporating the personalized information our tests provide.A list of the latest Castle Biosciences Inc News - CSTL Stock News, Press Releases, Earnings Report, Financial Disclosures, Offerings, Acquisitions.Castle Biosciences Inc’s price is currently up 15.45% so far this month. During the month of July, Castle Biosciences Inc’s stock price has reached a high of $20.96 and a low of $13.18. Over the last year, Castle Biosciences Inc has hit prices as high as $36.10 and as low as $9.26.